BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Stratos Genomics Receives Grant From the National National Human Genome Research Institute for Further Development of Sequencing by Expansion(TM) Technology


8/24/2011 8:36:15 AM

SEATTLE, WA--(Marketwire - August 23, 2011) -

Stratos Genomics Inc. today announced receipt of grant funds from the National Human Genome Research Institute (NHGRI) in the amount of $829,000 over two years. The NHGRI, part of the National Institutes of Health (NIH), awarded $14 million to nine qualifying research organizations on Monday, August 22, 2011, to support the development of revolutionary DNA sequencing technologies.

Stratos Genomics will utilize the grant funds to further development of its ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics. "We are excited to receive this award and grateful to have the support of NHGRI," said Mark Kokoris, Chief Science Officer and principal investigator for the grant. "The additional funding will allow us to expand our development efforts and bring us one step closer to realizing the enormous potential of our Sequencing by Expansion™ technology."

"We are confident that NHGRI grantees will continue to make major breakthroughs in the development of technologies that will sequence a human genome for $1,000 or less," NHGRI Director Eric D. Green, M.D, Ph.D., said in a press release dated April 22, 2011. "As genome sequencing costs continue to decline, researchers and clinicians can increase the scale and scope of their studies. We will continue to fund innovations to accelerate what is known about human health and disease."

Read the grant abstracts and more details about the NHGRI genome technology program at http://www.genome.gov/10000368#al-6.

About Stratos Genomics Inc.
Stratos Genomics' goal is to establish the next gold standard of DNA sequencing with its "Sequencing by Expansion™" (SBX™) method. SBX is a simple, elegant, single-molecule detection process that circumvents the limitations of competing technologies, allowing accurate, ultra-low-cost whole genome sequencing. Established in 2007, Stratos Genomics Inc. is a spin-off of Seattle-based Stratos Group LLC.

About Stratos Group LLC
Stratos Group is dedicated to the conversion of science and technology into commercial solutions for the advancement of mankind and the protection of the environment. Also under the Stratos Group umbrella is Stratos Product Development LLC. Stratos Product Development is a world leader in technology product development services.


MEDIA CONTACT:
Rebecca Dawson
Director, Marketing Communications
Email Contact
(206) 448-1388
www.stratosgenomics.com

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES